NCT01880541

Brief Summary

The emergence of cognitive disorders after surgery under general anesthesia (GA) is the second leading cause of patient complaints (after dental debris caused by intubation techniques). These cognitive disorders can range from simple reversible confusion (26%) with postoperative cognitive dysfunction without actual recovery (10%). The hypnosedation is an ancient technique of anesthesia expanding its effects on cognitive function remain to this day unknown, but appear promising.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

November 6, 2012

Completed
8 months until next milestone

First Posted

Study publicly available on registry

June 19, 2013

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
4.3 years until next milestone

Results Posted

Study results publicly available

March 4, 2022

Completed
Last Updated

March 4, 2022

Status Verified

December 1, 2021

Enrollment Period

5.9 years

First QC Date

November 6, 2012

Results QC Date

December 10, 2021

Last Update Submit

March 3, 2022

Conditions

Keywords

Patients with breast cancer and breast surgery requiring

Outcome Measures

Primary Outcomes (1)

  • Presence of Cognitive Impairment

    Cognitive impairment is assessed using the MMSE questionnaire (MINI-MENTAL STATE EXAMINATION). the MMSE total score ranges from 0 (alteration of cognition) to 30 (no alteration)

    on the 7th day following surgery

Secondary Outcomes (1)

  • Presence of Cognitive Impairment

    1 month after surgery

Study Arms (2)

hypnosedation

EXPERIMENTAL

hypnosedation

Other: hypnosedation

general anesthesia

OTHER

general anesthesia

Other: general anesthésia

Interventions

hypnosedation

hypnosedation

general anesthesia

general anesthesia

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female, over 18 and under 80 years
  • Diagnosis of breast cancer established (Pathology)
  • Life expectancy greater than 6 months
  • Surgery of breast lumpectomy with or without lymph node dissection, mastectomy with or without lymph node dissection, dissection isolated
  • ASA 1 (healthy patient) or 2 (patient with moderate to high function) according to the classification of the American Society of Anesthesiologist,
  • Affiliation to a social security scheme,
  • Information on the study, signed informed consent

You may not qualify if:

  • Presence of major psychiatric disorders or psychotic behavior addiction, evaluated by neuropsychologist at the first preoperative consultation, through the test MINI (MINI\> 4 positive responses for each module)
  • Presence of neurological disorders known untreated or evaluated by neuropsychologist at the first preoperative consultation, with the MMSE test (MMSE \<24)
  • Patient treated morphine orally for 3 months or more
  • Patient is pregnant or nursing, or of childbearing potential and not using adequate contraception,
  • Patient included in another clinical study
  • Inability to undergo medical monitoring study for geographical, social or psychological
  • Patient deprived of liberty and most subject to a measure of legal protection or unable to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Centre Paul Strauss

Strasbourg, Alsace, 67000, France

Location

Institut Bergonié

Bordeaux, Aquitaine, 33000, France

Location

Centre Oscar Lambret

Lille, Nord, 59000, France

Location

MeSH Terms

Interventions

Hypnosis, Anesthetic

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and Analgesia

Results Point of Contact

Title
Pr Simone Mathoulin-Pélissier
Organization
Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR

Study Officials

  • COLOMBANI Sylvie, MD

    Institut Bergonié

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 6, 2012

First Posted

June 19, 2013

Study Start

December 1, 2010

Primary Completion

November 1, 2016

Study Completion

December 1, 2017

Last Updated

March 4, 2022

Results First Posted

March 4, 2022

Record last verified: 2021-12

Locations